$XOMA Headlines S&P 500 stages ‘the expected
Post# of 74576
Posted On: 09/12/2014 10:15:28 AM
$XOMA Headlines
S&P 500 stages ‘the expected’ break to all-time highs 1:04 p.m. Feb. 28, 2014 - Michael Ashbaugh
Restoration Hardware shares fall on co-CEO resigning 7:07 p.m. Dec. 12, 2013 - Wallace Witkowski
3 new bets by a biotech hedge fund 4:56 a.m. July 10, 2012 - The Trading Deck
XOMA wins US rights to market blood pressure drugs 6:56 p.m. Jan. 17, 2012 - MarketWatch.com
Can the Uptrend Continue for XOMA Corp (XOMA)? - Tale of the Tape 37 min ago - Zacks.com
XOMA Corporation (XOMA) Jumps: Stock Rises 6.2% - Tale of the Tape 9:11 a.m. Sept. 5, 2014 - Zacks.com
Increased Earnings Estimates Seen for XOMA Corp (XOMA): Can It Move Higher? - Tale of the Tape 8:55 a.m. Sept. 2, 2014 - Zacks.com
Wedbush Securities' Liana Moussatos On The Art And Science Of Picking Biotechs With Upside 12:01 p.m. Aug. 22, 2014 - Seeking Alpha
5 Red-Hot Biotech Stocks 1:14 a.m. Aug. 19, 2014 - InvestorPlace.com
XOMA's (XOMA) CEO John Varian on Q2 2014 Results - Earnings Call Transcript 10:44 p.m. Aug. 7, 2014 - Seeking Alpha
XOMA (XOMA) Q2 2014 Results - Earnings Call Webcast 4:25 p.m. Aug. 7, 2014 - Seeking Alpha
3 Biotech Catalyst Stocks To Own 9:04 a.m. July 31, 2014 - Seeking Alpha
XOMA's CEO Presents at EYEGUARD-B Communication Plan Update Conference (Transcript) 12:46 p.m. July 1, 2014 - Seeking Alpha
2 Attractive, But Speculative Biotechs For Less Than $5 1:04 p.m. June 9, 2014 - Seeking Alpha
Insider Trading Alert - ITMN, WAC And XOMA Traded By Insiders 12:30 p.m. May 16, 2014 - TheStreet.com
XOMA's (XOMA) CEO John Varian Presents at Bank of America Merrill Lynch 2014 Healthcare Conference (Transcript) 12:45 a.m. May 15, 2014 - Seeking Alpha
XOMA Posts Wider Q1 Loss - Analyst Blog 4:00 p.m. May 9, 2014 - Zacks.com
XOMA's (XOMA) CEO John Varian on Q1 2014 Results - Earnings Call Transcript 11:02 p.m. May 7, 2014 - Seeking Alpha
Xoma bounces 2:42 p.m. April 29, 2014 - Seeking Alpha
Why XOMA (XOMA) Stock Is Surging Today 12:35 p.m. April 29, 2014 - TheStreet.com
First Week Of December 20th Options Trading For XOMA 12:45 p.m. April 22, 2014 - TheStreet.com
The Recent Performance of 'Baker Brother Biotech Stocks' is Awful 12:23 p.m. April 15, 2014 - TheStreet.com
Biotech Stock Roundup: Amgen, Regeneron Slide on PCSK9 Inhibitor Concerns - Analyst Blog 10:50 a.m. March 12, 2014 - Zacks.com
XOMA's CEO Discusses Q4 2013 Results - Earnings Call Transcript 10:39 p.m. March 5, 2014 - Seeking Alpha
Pre-Market Review on Biotech Equities -- Exelixis, Novavax, Achillion Pharma, XOMA, and Amicus Therapeutics 8:50 a.m. Aug. 13, 2014 - PR Newswire - PRF
Global Uveitis Market 2014-2018.pdf 2:38 p.m. Aug. 12, 2014 - PR Newswire - PRF
XOMA Highlights Recent Achievements and Reports Financial Results for Second Quarter 2014 4:02 p.m. Aug. 7, 2014 - GlobeNewswire
XOMA to Present at Two Upcoming Investor Conferences 2:56 p.m. Aug. 6, 2014 - GlobeNewswire
XOMA to Announce Second Quarter 2014 Financial Results and Host Webcast on August 7 1:16 p.m. July 30, 2014 - GlobeNewswire
Pre-market Equity Watch on Biotech Industry -- Research on Halozyme Therapeutics, XOMA, Amicus Therapeutics, and Arena Pharma 7:20 a.m. July 10, 2014 - PR Newswire - PRF
XOMA Call Today at 4:30pm ET/1:30pm PT to Confirm Communication Plan for EYEGUARD(TM)-B Clinical Program 4:02 p.m. June 30, 2014 - GlobeNewswire
Health Care Sector Stocks Highlight -- Research on XOMA, Novartis, Catamaran, and Castlight Health 5:20 a.m. June 2, 2014 - PR Newswire - PRF
XOMA to Present at the Jefferies Global Healthcare Conference 3:01 p.m. May 28, 2014 - GlobeNewswire
XOMA to Present at the Bank of America Merrill Lynch Health Care Conference 3:31 p.m. May 12, 2014 - GlobeNewswire
XOMA Reports First Quarter 2014 Operational Highlights and Financial Results 4:03 p.m. May 7, 2014 - GlobeNewswire
Positive Data, Financial Results, and Drug Development Programs - Analyst Notes on Novavax, Ironwood, XOMA, Luminex and Amicus 8:00 a.m. May 2, 2014 - PR Newswire - PRF
Technical Data on Top Gainers -- Research on XOMA, ServiceNow, Ctrip.com, and Splunk 4:26 a.m. May 1, 2014 - PR Newswire - PRF
XOMA to Announce First Quarter 2014 Financial Results and Host Webcast on May 7 1:26 p.m. April 30, 2014 - GlobeNewswire
XOMA Finalizes Plans for Gevokizumab Phase 3 Clinical Program in Pyoderma Gangrenosum 9:01 a.m. April 28, 2014 - GlobeNewswire
Healthcare Companies Report Financial Results, Partnerships, and Recognitions - Analyst Notes on Keryx, WellCare, Zogenix, Orexigen Therapeutics, and XOMA 8:00 a.m. March 19, 2014 - PR Newswire - PRF
Technical Roundup - Most Active: J. C. Penney, XOMA, BlackBerry and Nokia 1:22 p.m. March 6, 2014 - PR Newswire - PRF
XOMA Reports 2013 Operational Highlights and Fourth Quarter and Full-Year 2013 Financial Results 5:58 p.m. March 4, 2014 - GlobeNewswire
XOMA Provides Update on Gevokizumab Proof-of-Concept Program 5:37 p.m. March 4, 2014 - GlobeNewswire
XOMA Receives Orphan Drug Designation From U.S. FDA for Pyoderma Gangrenosum 7:21 p.m. Feb. 24, 2014 - GlobeNewswire
S&P 500 stages ‘the expected’ break to all-time highs 1:04 p.m. Feb. 28, 2014 - Michael Ashbaugh
Restoration Hardware shares fall on co-CEO resigning 7:07 p.m. Dec. 12, 2013 - Wallace Witkowski
3 new bets by a biotech hedge fund 4:56 a.m. July 10, 2012 - The Trading Deck
XOMA wins US rights to market blood pressure drugs 6:56 p.m. Jan. 17, 2012 - MarketWatch.com
Can the Uptrend Continue for XOMA Corp (XOMA)? - Tale of the Tape 37 min ago - Zacks.com
XOMA Corporation (XOMA) Jumps: Stock Rises 6.2% - Tale of the Tape 9:11 a.m. Sept. 5, 2014 - Zacks.com
Increased Earnings Estimates Seen for XOMA Corp (XOMA): Can It Move Higher? - Tale of the Tape 8:55 a.m. Sept. 2, 2014 - Zacks.com
Wedbush Securities' Liana Moussatos On The Art And Science Of Picking Biotechs With Upside 12:01 p.m. Aug. 22, 2014 - Seeking Alpha
5 Red-Hot Biotech Stocks 1:14 a.m. Aug. 19, 2014 - InvestorPlace.com
XOMA's (XOMA) CEO John Varian on Q2 2014 Results - Earnings Call Transcript 10:44 p.m. Aug. 7, 2014 - Seeking Alpha
XOMA (XOMA) Q2 2014 Results - Earnings Call Webcast 4:25 p.m. Aug. 7, 2014 - Seeking Alpha
3 Biotech Catalyst Stocks To Own 9:04 a.m. July 31, 2014 - Seeking Alpha
XOMA's CEO Presents at EYEGUARD-B Communication Plan Update Conference (Transcript) 12:46 p.m. July 1, 2014 - Seeking Alpha
2 Attractive, But Speculative Biotechs For Less Than $5 1:04 p.m. June 9, 2014 - Seeking Alpha
Insider Trading Alert - ITMN, WAC And XOMA Traded By Insiders 12:30 p.m. May 16, 2014 - TheStreet.com
XOMA's (XOMA) CEO John Varian Presents at Bank of America Merrill Lynch 2014 Healthcare Conference (Transcript) 12:45 a.m. May 15, 2014 - Seeking Alpha
XOMA Posts Wider Q1 Loss - Analyst Blog 4:00 p.m. May 9, 2014 - Zacks.com
XOMA's (XOMA) CEO John Varian on Q1 2014 Results - Earnings Call Transcript 11:02 p.m. May 7, 2014 - Seeking Alpha
Xoma bounces 2:42 p.m. April 29, 2014 - Seeking Alpha
Why XOMA (XOMA) Stock Is Surging Today 12:35 p.m. April 29, 2014 - TheStreet.com
First Week Of December 20th Options Trading For XOMA 12:45 p.m. April 22, 2014 - TheStreet.com
The Recent Performance of 'Baker Brother Biotech Stocks' is Awful 12:23 p.m. April 15, 2014 - TheStreet.com
Biotech Stock Roundup: Amgen, Regeneron Slide on PCSK9 Inhibitor Concerns - Analyst Blog 10:50 a.m. March 12, 2014 - Zacks.com
XOMA's CEO Discusses Q4 2013 Results - Earnings Call Transcript 10:39 p.m. March 5, 2014 - Seeking Alpha
Pre-Market Review on Biotech Equities -- Exelixis, Novavax, Achillion Pharma, XOMA, and Amicus Therapeutics 8:50 a.m. Aug. 13, 2014 - PR Newswire - PRF
Global Uveitis Market 2014-2018.pdf 2:38 p.m. Aug. 12, 2014 - PR Newswire - PRF
XOMA Highlights Recent Achievements and Reports Financial Results for Second Quarter 2014 4:02 p.m. Aug. 7, 2014 - GlobeNewswire
XOMA to Present at Two Upcoming Investor Conferences 2:56 p.m. Aug. 6, 2014 - GlobeNewswire
XOMA to Announce Second Quarter 2014 Financial Results and Host Webcast on August 7 1:16 p.m. July 30, 2014 - GlobeNewswire
Pre-market Equity Watch on Biotech Industry -- Research on Halozyme Therapeutics, XOMA, Amicus Therapeutics, and Arena Pharma 7:20 a.m. July 10, 2014 - PR Newswire - PRF
XOMA Call Today at 4:30pm ET/1:30pm PT to Confirm Communication Plan for EYEGUARD(TM)-B Clinical Program 4:02 p.m. June 30, 2014 - GlobeNewswire
Health Care Sector Stocks Highlight -- Research on XOMA, Novartis, Catamaran, and Castlight Health 5:20 a.m. June 2, 2014 - PR Newswire - PRF
XOMA to Present at the Jefferies Global Healthcare Conference 3:01 p.m. May 28, 2014 - GlobeNewswire
XOMA to Present at the Bank of America Merrill Lynch Health Care Conference 3:31 p.m. May 12, 2014 - GlobeNewswire
XOMA Reports First Quarter 2014 Operational Highlights and Financial Results 4:03 p.m. May 7, 2014 - GlobeNewswire
Positive Data, Financial Results, and Drug Development Programs - Analyst Notes on Novavax, Ironwood, XOMA, Luminex and Amicus 8:00 a.m. May 2, 2014 - PR Newswire - PRF
Technical Data on Top Gainers -- Research on XOMA, ServiceNow, Ctrip.com, and Splunk 4:26 a.m. May 1, 2014 - PR Newswire - PRF
XOMA to Announce First Quarter 2014 Financial Results and Host Webcast on May 7 1:26 p.m. April 30, 2014 - GlobeNewswire
XOMA Finalizes Plans for Gevokizumab Phase 3 Clinical Program in Pyoderma Gangrenosum 9:01 a.m. April 28, 2014 - GlobeNewswire
Healthcare Companies Report Financial Results, Partnerships, and Recognitions - Analyst Notes on Keryx, WellCare, Zogenix, Orexigen Therapeutics, and XOMA 8:00 a.m. March 19, 2014 - PR Newswire - PRF
Technical Roundup - Most Active: J. C. Penney, XOMA, BlackBerry and Nokia 1:22 p.m. March 6, 2014 - PR Newswire - PRF
XOMA Reports 2013 Operational Highlights and Fourth Quarter and Full-Year 2013 Financial Results 5:58 p.m. March 4, 2014 - GlobeNewswire
XOMA Provides Update on Gevokizumab Proof-of-Concept Program 5:37 p.m. March 4, 2014 - GlobeNewswire
XOMA Receives Orphan Drug Designation From U.S. FDA for Pyoderma Gangrenosum 7:21 p.m. Feb. 24, 2014 - GlobeNewswire
(0)
(0)